- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00583687
Pulse Contour Analysis and Tissue Oxymetry in Changing Vascular Tone
April 27, 2009 updated by: University Hospital Inselspital, Berne
The purpose of this study is to compare changes of minimally invasive arterial pulse contour cardiac output with changes of intermittent and continuous thermodilution cardiac output by pulmonary artery catheter in hemodynamic unstable patients with rapid changing vascular tone (changing dosage of vasoactive drugs or inotropics, or volume challenge).
Simultaneously, global parameters of oxygen delivery and consumption will be compared with regional flow parameters and tissue oxymetry (near infrared spectrometry and laser-Doppler).
While continuous thermodilution cardiac output is used for patient management, pulse contour cardiac output, intermittent thermodilution cardiac output and tissue oxymetry is only used for monitoring.
Study Overview
Status
Completed
Intervention / Treatment
- Device: Vigileo TM / Flotrac TM (Minimally invasive cardiac output system consisting of arterial line sensor and cardiac output monitor)
- Other: Passive leg raising
- Other: Volume challenge / Change of vasoactive drugs or inotropics
- Device: Inspectra TM/O-To-See TM (Tissue oxymetry with near infrared spectroscopy and laser-Doppler)
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bern, Switzerland, 3010
- Department of Intensive Care Medicine, University Hospital Inselspital, Berne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Indication for invasive hemodynamic monitoring with pulmonary artery catheter and arterial catheter
- Hemodynamic instability (need for vasoactive drugs, inotropics or volume).
Exclusion Criteria:
- Age < 18.
- Patient with contraindications for the placement of arterial cannula.
- Patient with history or clinical findings of aortic valve regurgitation.
- Atrial fibrillation.
- Patient being treated with an intra-aortic balloon pump.
- Limitation of therapy due to bad prognosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes of cardiac output measured by three different techniques during changes of vascular tone
Time Frame: 2 hours
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Prediction of fluid responsiveness with minimally invasive arterial pulse contour analysis in hemodynamic unstable patients.
Time Frame: 2 hours
|
2 hours
|
|
Comparison of global parameters of oxygen delivery and consumption with local parameters of flow and tissue oxymetry during changes of vascular tone.
Time Frame: 2 hours
|
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Christoph C Ganter, M.D., Department of Intensive Care Medicine, University Hospital, Inselspital, Berne
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2007
Primary Completion (ACTUAL)
January 1, 2009
Study Completion (ACTUAL)
January 1, 2009
Study Registration Dates
First Submitted
December 18, 2007
First Submitted That Met QC Criteria
December 20, 2007
First Posted (ESTIMATE)
December 31, 2007
Study Record Updates
Last Update Posted (ESTIMATE)
April 28, 2009
Last Update Submitted That Met QC Criteria
April 27, 2009
Last Verified
April 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KEK-3107-UHB-1316
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.